, , p.32
Remodelling the extracellular matrix in development and disease, Nature reviews. Molecular cell biology 15, vol.12, p.40, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01952416
Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases". en, Genes, Chromosomes and Cancer 28, vol.2, pp.1098-2264, 2000. ,
,
,
, , p.40
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards". eng, Nature Communications, vol.7, p.71, 2016. ,
Epistemology of the origin of cancer: a new paradigm, BMC cancer, vol.14, p.35, 2014. ,
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon, 1999. ,
, Nature Medicine 5, vol.8, p.50
Oncology meets immunology: the cancerimmunity cycle". eng, Immunity 39.1, p.43, 2013. ,
Inflammatory responses and inflammation-associated diseases in organs, Oncotarget 9, vol.6, pp.1949-2553, 2017. ,
The Sapir-Whorf hypothesis in the domain of colors: evidence from healthy and aphasic speakers". en, Rivista Italiana di Filosofia del Linguaggio, vol.3, pp.1-14, 2013. ,
Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation". eng, The Journal of Experimental Medicine, vol.210, p.50, 2013. ,
Human dendritic cell subsets: an update, Immunology 154, vol.1, pp.19-2805, 2018. ,
Human dendritic cell subsets, Immunology 140.1, vol.167, pp.19-2805, 2013. ,
Plasmacytoid dendritic cells in immunity, Nature Immunology 5, vol.12, p.50, 2004. ,
A survey of best practices for RNA-seq data analysis". eng, Genome Biology, vol.17, p.62, 2016. ,
Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2Positive Breast Cancer". en, Journal of Clinical Oncology, vol.30, p.39, 2012. ,
Reactome: a database of reactions, pathways and biological processes". eng, Nucleic Acids Research, vol.39, p.62, 2011. ,
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature 486.7403, pp.346-352, 2012. ,
Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming, The EMBO Journal, vol.33, pp.261-4189, 2014. ,
, , p.53, 201488027.
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors". eng, Lancet, p.36, 2005. ,
Interactions between lymphocytes and myeloid cells regulate proversus anti-tumor immunity, eng. In: Cancer Metastasis Reviews, vol.29, p.35, 2010. ,
CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages". eng, Cancer Cell, vol.16, issue.2, pp.1878-3686, 2009. ,
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy". en, Cancer Discovery. issn, p.43, 2011. ,
DAVID: Database for Annotation, Visualization, and Integrated Discovery, Genome Biology 4.9, p.62, 2003. ,
Type I interferon is selectively required by dendritic cells for immune rejection of tumors, The Journal of experimental medicine 208, vol.10, p.170, 2011. ,
A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis, Briefings in Bioinformatics, vol.14, p.60, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01521274
STAR: ultrafast universal RNA-seq aligner". en, Bioinformatics 29.1, p.60, 2013. ,
, Interferon, p.170, 2017.
Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity". eng, Frontiers in Immunology, vol.4, p.173, 2013. ,
Cancer immunoediting: from immunosurveillance to tumor escape, Nature Immunology, vol.3, p.42, 2002. ,
The immunobiology of cancer immunosurveillance and immunoediting". eng, Immunity 21, vol.2, p.35, 2004. ,
A critical function for type I interferons in cancer immunoediting, Nature immunology 6.7, p.170, 2005. ,
Relevance of tumor-infiltrating lymphocytes in breast cancer". en, BMC Medicine 13.1. issn, p.39, 2015. ,
ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells". eng, Cancer Research 72, vol.23, pp.6130-6141, 2012. ,
Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells, 2014. ,
, Frontiers in Immunology, vol.5, p.32
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells, J Exp Med, vol.208, p.170, 2011. ,
Adequate immune response ensured by binary IL-2 and graded CD25 expression in a murine transfer model, p.32, 2018. ,
Myeloid-derived suppressor cells as regulators of the immune system, Nature Reviews. Immunology, vol.9, p.43, 2009. ,
Innate and adaptive immune cells in the tumor microenvironment". eng, Nature Immunology, vol.14, p.169, 2013. ,
Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting". eng, Clinical Medicine Insights. Oncology, vol.10, p.39, 2016. ,
Dendritic Cells and Cancer Immunity, Trends in Immunology, vol.37, pp.1471-4906, 2016. ,
,
Breast Cancer Cell-Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes, 2015. ,
, Cancer Research 75, vol.14, p.71
Tissue-Resident Macrophage Ontogeny and Homeostasis". eng, pp.439-449, 2016. ,
, , vol.56, p.34
Monocytes and macrophages: developmental pathways and tissue homeostasis, 2014. ,
, Nature Reviews. Immunology, vol.14, p.45
Alternative activation of macrophages". eng, Nature Reviews, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-00474829
, , p.46
Environment drives selection and function of enhancers controlling tissue-specific macrophage identities". eng, Cell 159, vol.6, p.34, 2014. ,
Constitutive type I interferon modulates homeostatic balance through tonic signaling, p.170, 2012. ,
Th17 pathway and prognosis in Triple Negative breast cancer, p.31 ,
Dendritic Cells Display Subset and Tissue-Specific Maturation Dynamics over, Human Life". eng. In: Immunity, vol.46, p.50, 2017. ,
, , 2012.
, Clonal evolution in cancer, Nature 481, vol.7381, p.39
Alternative expression analysis by RNA sequencing". eng, Nature Methods 7.10, p.171, 2010. ,
KEGG: Kyoto Encyclopedia of Genes and Genomes, Nucleic Acids Research, vol.28, p.62, 2000. ,
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2". eng, Science, vol.302, p.36, 2003. ,
Comprehensive molecular portraits of human breast tumours". en. In: Nature 490, vol.7418, p.37, 2012. ,
Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy, Molecular Cell, vol.60, p.38, 2015. ,
Cooperation and the evolution of intelligence". en, Proc, 2012. ,
, , p.27
Tumour heterogeneity and cancer cell plasticity". eng. In: Nature 501, vol.7467, p.39, 2013. ,
Origin and physiological roles of inflammation". eng, p.34, 2008. ,
Development and function of dendritic cell subsets". eng, Immunity 40.5, p.167, 2014. ,
Deciphering the transcriptional network of the DC lineage, Nature immunology, vol.13, p.168, 2012. ,
DNA microarrays and beyond: completing the journey from tissue to cell, Nature Cell Biology, vol.3, p.57, 2001. ,
The Dark Side of IFN-gamma: Its Role in Promoting Cancer Immunoevasion, International journal of molecular sciences 19.1. issn, p.171, 2017. ,
T-cell homing specificity and plasticity: new concepts and future challenges, 2006. ,
, Trends in Immunology, vol.27, issue.06, p.33
Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells". eng. In: Nature 424, vol.6944, p.168, 2003. ,
Mapping and quantifying mammalian transcriptomes by RNA-Seq". eng, Nature Methods 5, vol.7, p.60, 2008. ,
Treatment strategy for HER2-positive breast cancer". eng, International Journal of Clinical Oncology, vol.15, p.39, 2010. ,
Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses". eng, Nature Immunology, vol.10, p.52, 2009. ,
Robust enumeration of cell subsets from tissue expression profiles, In: Nature methods, vol.12, pp.1-10, 2014. ,
,
, , p.57
The structure and function of complex networks, SIAM Review 45, vol.2, p.31, 2003. ,
A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection". eng, The New England Journal of Medicine, vol.335, p.29, 1996. ,
Shedding light on the cell biology of extracellular vesicles, 2018. ,
, Nature Reviews. Molecular Cell Biology, vol.19, p.26
, , 2013.
, The origins of multicellular organisms, Evolution & Development, vol.15, p.28
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses". eng, Blood 122, vol.6, p.50, 2013. ,
Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature". eng, pp.19-2805, 1994. ,
High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors". eng, The American Journal of Pathology, vol.174, p.62, 2009. ,
Gene Expression Analysis of Macrophages That Facilitate Tumor Invasion Supports a Role for Wnt-Signaling in Mediating Their Activity in Primary Mammary Tumors". en, The Journal of Immunology, vol.184, pp.1550-6606, 2010. ,
Tissue biology perspective on macrophages, Nature Immunology, vol.17, p.34, 2016. ,
Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin". eng, Proceedings of the National Academy of Sciences of the United States of America 94, vol.23, p.50, 1997. ,
Embryonic Neural Stem Cell Differentiation to Aldynoglia Induced by Olfactory Bulb Ensheathing Cell-Conditioned Medium, p.58, 2011. ,
, CTLA-4 and PD, 2013.
, New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients". en. In: Clinical Cancer Research, vol.19, pp.5300-5309
Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients, Genes, Chromosomes & Cancer, vol.22, p.40, 1998. ,
Antitumour actions of interferons: implications for cancer therapy, Nature reviews. Cancer, vol.16, p.171, 2016. ,
An overview of the immune system, eng. In: Lancet (London, p.45, 2001. ,
Population robustness arising from cellular heterogeneity". en, Proceedings of the National Academy of Sciences 107.25, p.32, 2010. ,
Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling, 2016. ,
, Cancer Research 76, vol.11, p.43
, , 2013.
, IRF4 transcription-factor-dependent
, Immunity 38.5, p.50
Large-scale detection and analysis of RNA editing in grape mtDNA by RNA deep-sequencing". eng, Nucleic Acids Research, vol.38, p.60, 2010. ,
Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cellmediated immunity to house dust mite allergen". eng, Immunity 38, vol.2, p.52, 2013. ,
Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics. en, 2018. ,
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells". eng, The Journal of Experimental Medicine, vol.207, p.50, 2010. ,
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer". eng, Breast cancer research: BCR 12.5, R68. issn: 1465-542X, p.38, 2010. ,
Clinical implications of the intrinsic molecular subtypes of breast cancer". eng, Breast (Edinburgh, Scotland) 24 Suppl, vol.2, p.37, 2015. ,
Sensing Pathogens and Tuning Immune Responses". en. In: Science 293, vol.5528, pp.36-8075, 2001. ,
The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome, eng. In: Oncoimmunology, vol.6, p.62, 2017. ,
Microenvironmental regulation of tumor progression and metastasis". In: Nature medicine 19, vol.11, p.40, 2013. ,
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases, p.31, 2015. ,
Social network architecture of human immune cells unveiled by quantitative proteomics". en, Nature Immunology, vol.18, pp.1529-2916, 2017. ,
Normalization of RNA-seq data using factor analysis of control genes or samples". eng, Nature Biotechnology, vol.32, p.60, 2014. ,
Reciprocal control of T helper cell and dendritic cell differentiation". eng, ) 283.5405, p.31, 1999. ,
limma powers differential expression analyses for RNAsequencing and microarray studies". eng, Nucleic Acids Research, vol.43, 2015. ,
Molecular and Cellular Heterogeneity in Breast Cancer, The American Journal of Pathology, vol.183, p.38, 2013. ,
De novo assembly and analysis of RNA-seq data". eng, Nature Methods 7.11, p.60, 2010. ,
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics 26.1, pp.1367-4803, 2010. ,
Single-Cell RNA Sequencing of Lymph Node Stromal Cells Reveals Niche-Associated Heterogeneity, English. In: Immunity 48, vol.5, pp.30143-30145, 2018. ,
CD16+ and CD16 human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+, 2001. ,
, International Immunology 13, vol.12, p.45
Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice, The Journal of Experimental Medicine, vol.191, p.171, 2000. ,
Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast, 2011. ,
, Cell 145, vol.6, p.41
IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses, eng. In: Immunity 38, vol.5, p.50, 2013. ,
Intestinal monocytes and macrophages are required for T cell polarization in response to Citrobacter rodentium, The Journal of Experimental Medicine, vol.210, p.52, 2013. ,
Mapping the human DC lineage through the integration of high-dimensional techniques, eng. In: Science, 2017. ,
Photocarcinogenesis and Skin Cancer Prevention Strategies". eng, Anticancer Research, vol.36, issue.3, p.30, 2016. ,
Inflammatory dendritic cells in mice and humans, Trends in Immunology, vol.34, pp.1471-4981, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00846095
, , vol.167, p.52
Human inflammatory dendritic cells induce Th17 cell differentiation". eng, Immunity 38, vol.2, p.52, 2013. ,
Microarray Data Analysis and Mining Tools, pp.95-99, 2011. ,
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer, British Journal of Cancer, vol.109, p.43, 2013. ,
Organ-specific features of natural killer cells". eng, Nature Reviews. Immunology, vol.11, p.33, 2011. ,
Macrophage plasticity and polarization: in vivo veritas". eng, The Journal of Clinical Investigation, vol.122, p.46, 2012. ,
The nature of the principal type 1 interferon-producing cells in human blood". eng, Science, vol.284, pp.36-8075, 1999. ,
A Brief Overview of the WHO Classification of Breast Tumors, 2013. ,
, Breast Care, p.37
Repeated observation of breast tumor subtypes in independent gene expression data sets". en. In: Proceedings of the National Academy of Sciences 100, vol.14, p.38, 2003. ,
Systems approaches to unravel innate immune cell diversity, environmental plasticity and functional specialization, Current opinion in immunology, vol.32, pp.952-7915, 2015. ,
Mechanisms of tumor escape in the context of the T-cellinflamed and the non-T-cell-inflamed tumor microenvironment". eng, International Immunology, vol.28, p.43, 2016. ,
Immunotherapeutic approaches in triplenegative breast cancer: latest research and clinical prospects". en, Therapeutic Advances in Medical Oncology 5.3, p.53, 2013. ,
,
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review". eng, JAMA oncology 2.10, p.169, 2016. ,
Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution". eng, The Journal of Experimental Medicine, vol.137, p.46, 1973. ,
Investigations of interferon-lambda for the treatment of cancer, Journal of innate immunity 7.3, p.170, 2015. ,
The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling, Frontiers in Oncology 4. issn: 2234-943X, 2014. ,
, Risk Factors and Preventions of Breast Cancer". eng. In: International Journal of Biological Sciences, vol.13, issue.11, p.36, 2017.
The Mechanisms of T Cell Selection in the, Thymus". English. In: Trends in Immunology, vol.38, issue.17, p.29, 2017. ,
Checkpoint Inhibitors in Breast Cancer: Changing the Therapeutic Landscape. en. url: https : / / am . asco . org / checkpoint -inhibitorsbreast-cancer-changing-therapeuticlandscape, p.44, 2018. ,
Single-cell NF-kappaB dynamics reveal digital activation and analogue information processing". eng, Nabreast cancer". eng. In: Breast Cancer Research and Treatment, vol.163, p.43, 2010. ,
Comprehensive analysis of immune evasion in breast cancer by single-cell RNA-seq". en. In: bioRxiv, p.368605, 2018. ,
Microbiota and autoimmunity: exploring new avenues". eng, Cell Host & Microbe, vol.17, pp.1934-6069, 2015. ,
, , p.35
Resident and "inflammatory" dendritic cells in human skin, The Journal of Investigative Dermatology 129, vol.2, p.52, 2009. ,
Unraveling the genetics of autoimmunity". eng, Cell 140, vol.6, p.35, 2010. ,
Prognostic value of tumor-infiltrating Foxp3+ regulatory T cells in patients with breast cancer: a meta-analysis, Journal of Cancer, vol.8, p.43, 2017. ,
Nomenclature of monocytes and dendritic cells in blood, Blood 116, vol.16, p.50, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00611173
T helper cell differentiation more than just cytokines". eng, Advances in Immunology, vol.109, pp.1557-8445, 2011. ,
,
, , vol.1
,
, , vol.8, p.9
, , vol.8, p.9
, Sandrine Niyongere, 10 M'boyba Khadija Diop, vol.8, p.4, 2009.
Eric Padron, 10 Vassili Soumelis, 5 Nathalie Droin, 1,4 Mrinal M Patnaik, 12* Eric Solary, 1,2,3* Running head: Clonal PDC in chronic myelomonocytic leukemia 1 -INSERM U1170, Gustave Roussy Cancer Center, Gustave Roussy Cancer Center, issue.7 ,
,
,
12 -Division of Hematology, Service d'hématologie biologique ,
FMS-like tyrosine kinase 3 is required for dendritic cell development in peripheral lymphoid tissues, Nat Immunol, vol.9, issue.6, pp.676-683, 2008. ,
Transcription Factor E2-2 Is an Essential and Specific Regulator of Plasmacytoid Dendritic Cell Development, Cell, vol.135, issue.1, p.48, 2008. ,
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny, Nat Rev Immunol, vol.14, issue.8, pp.571-579, 2014. ,
The nature of the principal type 1 interferonproducing cells in human blood, Science, vol.284, issue.5421, pp.1835-1842, 1999. ,
Antigen-Presentation Properties of Plasmacytoid Dendritic Cells, Immunity, vol.29, issue.3, p.61, 2008. ,
Natural Interferon / -Producing Cells Link Innate and Adaptive Immunity, J Exp Med, vol.192, issue.2, pp.219-245, 2000. ,
Plasmacytoid dendritic cells and cancer, J Leukoc Biol, vol.90, issue.4, p.90, 2011. ,
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells, Nat Med, vol.7, issue.12, pp.1339-1385, 2001. ,
Plasmacytoid Dendritic Cells Induce CD8+ Regulatory T Cells In Human Ovarian Carcinoma, Cancer Res, vol.65, issue.12, pp.5020-5026, 2005. ,
Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3+ T-Regulatory Cells, Cancer Res, vol.72, issue.20, pp.5240-5249, 2012. ,
Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms, J Leukoc Biol, vol.93, issue.3, pp.343-52, 2013. ,
Depletion and impaired interferon--producing capacity of blood plasmacytoid dendritic cells in human Tcell leukaemia virus type I-infected individuals, Br J Haematol, vol.125, issue.5, p.75, 2004. ,
Blood dendritic cells in patients with chronic lymphocytic leukaemia, Immunobiology, vol.213, issue.6, pp.493-501, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00483520
Turning the tide in myelodysplastic / myeloproliferative neoplasms, Nat Rev Cancer, vol.17, issue.7, p.40, 2017. ,
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, vol.127, issue.20, pp.2391-405, 2016. ,
Prognostic score including gene mutations in chronic myelomonocytic leukemia, J Clin Oncol, vol.31, pp.2428-2464, 2013. ,
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents, Nat Commun, vol.7, p.10767, 2016. ,
Clonal architecture of chronic myelomonocytic leukemias, Blood, vol.121, issue.12, pp.2186-98, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00923316
GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia, Blood, vol.121, issue.25, p.5068, 2013. ,
Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management, Am J Hematol, vol.91, issue.6, p.42, 2016. ,
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel, Blood, vol.129, issue.13, pp.1753-62, 2017. ,
How I treat chronic myelomonocytic leukemia, Blood, vol.130, issue.2, p.36, 2017. ,
Histologic and Immunohistochemical Study of Bone Marrow Monocytic Nodules in 21 Cases With Myelodysplasia, Am J Clin Pathol, vol.120, issue.6, p.81, 2003. ,
Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders, Am J Surg Pathol, vol.28, issue.5, p.95, 2004. ,
Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology, Mod Pathol, vol.19, issue.12, pp.1536-1581, 2006. ,
Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization, Am J Surg Pathol, vol.15, issue.1, p.95, 1991. ,
Malignant lymphoma of plasmacytoid T-cells. Morphologic and immunologic studies characterizing a special type of T-cell, Am J Surg Pathol, vol.7, issue.8, pp.849-62 ,
,
Immunohistochemical evidence for their monocyte/macrophage origin, Am J Pathol, vol.133, issue.1, p.15, 1988. ,
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors, Science, vol.356, issue.6335, p.4573, 2017. ,
Mapping the human DC lineage through the integration of high-dimensional techniques, Science, vol.356, issue.6342, p.3009, 2017. ,
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia, Blood, vol.121, issue.15, pp.3005-3020, 2013. ,
Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia, Blood Cancer J, vol.6, issue.1, pp.385-416, 2016. ,
Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors, Annu Rev Immunol, vol.23, issue.1, pp.275-306, 2005. ,
TermFinder-open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes, Bioinformatics, vol.20, issue.18, pp.3710-3715, 2004. ,
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters, OMICS : a Journal of Integrative Biology, vol.16, issue.5, pp.284-287, 2012. ,
Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow, J Exp Med, vol.212, issue.3, pp.385-99, 2015. ,
Clonal analysis of human dendritic cell progenitor using a stromal cell culture, J Immunol Methods, vol.425, p.21, 2015. ,
Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors, Blood, vol.103, issue.7, pp.2547-53, 2004. ,
Production of large numbers of plasmacytoid dendritic cells with functional activities from CD34+ hematopoietic progenitor cells: Use of interleukin-3, Exp Hematol, vol.40, issue.4, pp.268-78, 2012. ,
CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value, Leukemia, vol.30, issue.4, pp.914-922, 2016. ,
Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow: Summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Ann Hematol, vol.96, issue.5, pp.765-77, 2016. ,
CD2 Distinguishes Two Subsets of Human Plasmacytoid Dendritic Cells with Distinct Phenotype and Functions, J Immunol, vol.182, issue.11, pp.6815-6838, 2009. ,
Type I interferons in anticancer immunity, Nat Rev Immunol, vol.15, pp.405-414, 2015. ,
Combinatorial flexibility of cytokine function during human T helper cell differentiation, Nat Commun, vol.5, p.3987, 2014. ,
Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone, Leukemia, vol.30, issue.4, p.81, 2016. ,
Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target, Cancer Cell, vol.16, issue.4, p.23, 2009. ,
Diversification of human plasmacytoid predendritic cells in response to a single stimulus, Nat Immunol, vol.19, issue.1, pp.63-75, 2018. ,
IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development, Cancer Cell, vol.20, issue.5, p.661, 2011. ,
Treatment of chronic myelogenous leukemia by blocking cytokine alterations found in normal stem and progenitor cells, Cancer Cell, vol.27, issue.5, p.671, 2015. ,
Interleukin-8 in cancer pathogenesis, treatment and follow-up, Cancer Treat Rev, vol.60, pp.24-31, 2017. ,
CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells, Blood, vol.128, issue.3, p.371, 2016. ,
Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemia, Blood, vol.82, issue.8, pp.2517-2542, 1993. ,
MIF-Induced Stromal PKC /IL8 Is Essential in Human Acute Myeloid Leukemia, Cancer Res, vol.77, issue.2, pp.303-314, 2017. ,
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells, Blood, vol.125, issue.20, p.3144, 2015. ,
The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis, Blood, vol.114, issue.4, p.43, 2009. ,
The Signal Transducer STAT5 Inhibits Plasmacytoid Dendritic Cell Development by Suppressing Transcription Factor IRF8, Immunity, vol.28, issue.4, p.20, 2008. ,
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML, Leukemia ,
FLT3-Mediated p38-MAPK Activation Participates in the Control of Megakaryopoiesis in Primary Myelofibrosis, Cancer Res, vol.71, issue.8, pp.2901-2916, 2011. ,
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS), Blood, vol.110, issue.3, p.50, 2007. ,
Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS), Leukemia, vol.23, issue.3, pp.510-518, 2008. ,
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome, Oncoimmunology, vol.5, issue.2, p.1062208, 2016. ,
Impaired IFN-Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression, Cancer Res, vol.72, issue.20, pp.5188-97, 2012. ,
A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells, Leukemia, vol.31, issue.12, pp.2652-2660, 2017. ,
, Alongside PD-1 + T cells within tumors, CD8 + PD-1 -ILT2 + T cells are a major intratumor cytotoxic population selectively inhibited by the immune checkpoint
, Alix Jacquier, vol.1, 2005.
3 Department of Medical Oncology ,
Republic of China the interest of therapeutic targeting of the HLA-G:ILT2 checkpoint in HLA-G-positive tumors, either concomitantly to anti-PD1/PD-L1 ,
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma, New Engl J Med, vol.373, pp.1803-1816, 2015. ,
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma, New Engl J Med, vol.378, pp.1277-90, 2018. ,
Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4, Oncoimmunology, vol.6, 2017. ,
Beyond the increasing complexity of the immunomodulatory HLA-G molecule, Blood, vol.111, pp.4862-70, 2008. ,
HLA-G: An Immune Checkpoint Molecule, Advances in immunology, vol.127, pp.33-144, 2015. ,
CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance, Blood, vol.110, pp.3936-3984, 2007. ,
Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17, Blood, vol.117, pp.7021-7052, 2011. ,
Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma, Cancer research, vol.61, pp.6838-6883, 2001. ,
URL : https://hal.archives-ouvertes.fr/hal-00092851
Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma, The American journal of pathology, vol.162, pp.501-509, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-00092847
Characterization of HLA-G expression in renal cell carcinoma, Tissue antigens, vol.74, pp.213-234, 2009. ,
Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms, Human immunology, vol.64, pp.1057-63, 2003. ,
HLA-G expression in malignant melanoma, Seminars in cancer biology, vol.17, pp.422-431, 2007. ,
HLA class Ia and Ib molecules and FOXP3+TILs in relation to the prognosis of malignant melanoma patients, Clinical Immunology, vol.183, pp.191-198, 2017. ,
Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer, Journal of cellular and molecular medicine, vol.14, pp.2318-2347, 2010. ,
Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer, Lung Cancer, vol.58, pp.267-74, 2007. ,
Rouas-Freiss N. In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance, International journal of cancer Journal international du cancer, vol.135, pp.2107-2124, 2014. ,
A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells, The Journal of experimental medicine, vol.186, pp.1809-1827, 1997. ,
The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions, Journal of Immunology, vol.165, pp.3742-55, 2000. ,
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients, European journal of immunology, vol.29, pp.1990-1999, 1999. ,
Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL, Journal of Immunology, vol.166, pp.3933-3974, 2001. ,
Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function, Immunology, vol.112, pp.531-573, 2004. ,
Does memory improve with age? CD85j (ILT-2/LIR-1) expression on CD81 T cells correlates with 'memory inflation' in human cytomegalovirus infection, Immunology and cell biology, vol.83, pp.182-190, 2005. ,
Immune Checkpoint Function of CD85j in CD8 T Cell Differentiation and Aging, Frontiers in immunology, vol.8, 2017. ,
Latent Cytomegalovirus Infection in Rheumatoid Arthritis and Increased Frequencies of Cytolytic LIR-1+CD8+T Cells, Arthritis & Rheumatology, vol.68, pp.337-383, 2016. ,
Coordinated expression of ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8(+) T cells, Journal of Immunology, vol.173, pp.7223-7232, 2004. ,
Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes, AIDS, vol.15, pp.965-74, 2001. ,
EMA -A R package for Easy Microarray data analysis, BMC research notes, vol.3, p.277, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00984710
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, Nature, vol.401, pp.708-720, 1999. ,
An Immune Atlas of Clear Cell Renal Cell Carcinoma, Cell, vol.169, pp.736-785, 2017. ,
The who's who of T-cell differentiation: human memory T-cell subsets, European journal of immunology, vol.43, pp.2797-809, 2013. ,
CD8+ CD28-and CD8+ CD57+ T cells and their role in health and disease, Immunology, vol.134, pp.17-32, 2011. ,
NKp80 defines and stimulates a reactive subset of CD8 T cells, Blood, vol.113, pp.358-69, 2009. ,
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates, Nature, vol.557, pp.575-584, 2018. ,
HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes, International immunology, vol.11, pp.1351-1357, 1999. ,
Clinical cancer research : an official journal of the American Association for, Cancer Research, vol.19, pp.5564-71, 2013. ,
,
, Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma. Clinical Cancer Research, vol.22, pp.5461-71, 2016.